FULGAVO Trademark

Trademark Overview

On Monday, January 14, 2013, a trademark application was filed for FULGAVO with the United States Patent and Trademark Office. The USPTO has given the FULGAVO trademark a serial number of 85822539. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 24, 2017. This trademark is owned by Novartis AG. The FULGAVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, hematology and oncology; Pharmaceutical preparations for use in transplantation; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations, namely, antivirals, antibiotics and antifungals
fulgavo

General Information

Serial Number85822539
Word MarkFULGAVO
Filing DateMonday, January 14, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 24, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system and the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, hematology and oncology; Pharmaceutical preparations for use in transplantation; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for use in the gastroenterological areas and for the prevention and treatment of ocular disorders or diseases; Pharmaceutical preparations, namely, anti-infectives; pharmaceutical preparations for treating bacterial-based diseases; Pharmaceutical preparations, namely, antivirals, antibiotics and antifungals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 18, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, April 24, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 24, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, September 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 15, 2016EXTENSION 5 GRANTED
Wednesday, September 14, 2016EXTENSION 5 FILED
Wednesday, September 14, 2016TEAS EXTENSION RECEIVED
Tuesday, March 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 14, 2016EXTENSION 4 GRANTED
Friday, March 11, 2016EXTENSION 4 FILED
Friday, March 11, 2016TEAS EXTENSION RECEIVED
Saturday, September 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 18, 2015EXTENSION 3 GRANTED
Wednesday, September 16, 2015EXTENSION 3 FILED
Wednesday, September 16, 2015TEAS EXTENSION RECEIVED
Saturday, April 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 17, 2015EXTENSION 2 GRANTED
Friday, March 13, 2015EXTENSION 2 FILED
Friday, April 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 13, 2015TEAS EXTENSION RECEIVED
Wednesday, September 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 15, 2014EXTENSION 1 GRANTED
Monday, September 15, 2014EXTENSION 1 FILED
Monday, September 15, 2014TEAS EXTENSION RECEIVED
Tuesday, March 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 13, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 13, 2013ASSIGNED TO LIE
Monday, November 18, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 5, 2013EXAMINER'S AMENDMENT ENTERED
Monday, November 4, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 4, 2013EXAMINERS AMENDMENT E-MAILED
Monday, November 4, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, October 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 10, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 10, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 29, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 29, 2013NON-FINAL ACTION E-MAILED
Monday, April 29, 2013NON-FINAL ACTION WRITTEN
Friday, April 26, 2013ASSIGNED TO EXAMINER
Friday, January 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 17, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

fulgavo pharmaceutical preparations system disorders treatment prevention diseases namely anti ocular